Literature DB >> 9228956

Why tyrosinase for treatment of melanoma.

Y H Song1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228956     DOI: 10.1016/S0140-6736(05)61810-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy.

Authors:  T A Colella; T N Bullock; L B Russell; D W Mullins; W W Overwijk; C J Luckey; R A Pierce; N P Restifo; V H Engelhard
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

2.  Isotope effects in mechanistic studies of l-tyrosine halogen derivatives hydroxylation catalyzed by tyrosinase.

Authors:  Małgorzata Pająk; Marianna Kańska
Journal:  J Radioanal Nucl Chem       Date:  2017-10-23       Impact factor: 1.371

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.